Drug Shortage Report for BUPIVACAINE INJECTION BP

Last updated on 2024-02-16 History
Report ID 213681
Drug Identification Number 02443686
Brand name BUPIVACAINE INJECTION BP
Common or Proper name BUPIVACAINE INJECTION BP
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) BUPIVACAINE HYDROCHLORIDE
Strength(s) 2.5MG
Dosage form(s) SOLUTION
Route of administration EPIDURAL BLOCK/INFILTRATION EPIDURAL BLOCK/INFILTRATION
Packaging size 10 VIALS X 20 ML
ATC code N01BB
ATC description ANESTHETICS, LOCAL
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2024-04-13
Actual start date
Estimated end date Unknown
Actual end date
Shortage status Anticipated shortage
Updated date 2024-02-16
Company comments Allocation reduced to 100% as of February 1st, 2024. Supplemental quantities will be available on Bupivacaine 0.5% as of February 21st, 2024.
Health Canada comments
Tier 3 Status Yes
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2024-02-16 French Compare
v8 2024-02-16 English Compare
v7 2024-02-16 French Compare
v6 2024-02-16 English Compare
v5 2024-01-29 French Compare
v4 2024-01-29 English Compare
v3 2024-01-22 English Compare
v2 2023-12-18 French Compare
v1 2023-12-18 English Compare

Showing 1 to 9 of 9